The effect of HCG therapy on the amount of sperm extraction in men with non-obstructive azoospermia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240222061085N1

Enrollment

Registered

2024-03-04

Start date

2024-03-19

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Male infertility

Interventions

Intervention 1: Intervention group: In patients who meet the study entry criteria, HCG will be prescribed as 5000 IU subcutaneous injection twice a week for 10 to 14 weeks. After the end of the HCG t

Eligibility

Sex/Gender

Male

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Male patients with infertility caused by non-obstructive azoospermia at least twice Semen Analysis

Exclusion criteria

Exclusion criteria: They received exogenous testosterone receive chemotherapy or radiotherapy at the time of study Unilateral or bilateral non-palpable testicles and Increased serum prolactin. Confirmed chromosomal abnormalities

Design outcomes

Primary

Measure	Time frame
The rate of sperm extraction in men with non-obstructive azoospermia. Timepoint: 3 months after receiving hcg. Method of measurement: Sperm analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdolRahman Kalkali

Zahedan University of Medical Sciences

Abdikalkali@gmail.com+98 915 285 7422

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026